BlossomHill Therapeutics
PrivateLast Round
Series B
Extension
Dec 10, 2025
Total Funding Raised
$343.65M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BlossomHill Therapeutics is a biopharmaceutical company that discovers and develops small molecule medicines for the treatment of high-need cancers and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BlossomHill Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
BlossomHill Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 10, 2025 | ||||
| Series B | Feb 29, 2024 | ||||
| Series B | Dec 28, 2023 | ||||
| Series A | Mar 3, 2021 |
Key People
Founding team and executive leadership
BlossomHill Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series B Extension |
| Janus Henderson Group | Series B Extension |
| H&D Asset Management | Series B |
| Cormorant Asset Management | Series B, Series B Extension, Series A |
| OrbiMed | Series B, Series B Extension, Series A |
| Brahma Capital | Series B Extension |
| Plaisance Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2026
Grew 17% QoQ, from 59 to 69 employees.
- Apr 21, 2026
Presented at the Mini Symposium at AACR 2026.
BlossomHill Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BlossomHill Therapeutics's valuation, stock price, and market status.